AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Infection Surveillance Solutions - Global Market Analysis & Forecast Report, 2019-2026 - ResearchAndMarkets.com

April 3, 2019

DUBLIN--(BUSINESS WIRE)--Apr 3, 2019--The “Global Infection Surveillance Solutions Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.

The global infection surveillance solutions market is set to grow from US$ 330.7 Mn in 2017 to US$ 934.7 Mn 2026 expanding at a CAGR of 12.4% from 2018 to 2026.

Lack of sanitation, non-adherence to prescribed medication and increasing trend of self-medication has resulted in antibiotic resistance by bacteria. There is an urgent requirement of a surveillance system to keep in check the proliferation of hospital-acquired infection and mortality associated with dreadful diseases such as pneumonia, tuberculosis, Ebola, malaria, etc. Rising public health awareness and proactive government policies to curb the deleterious effect associated with infectious disease drive the infection surveillance solutions market growth.

Software solutions are garnering huge growth in the product segment for infection surveillance solutions market. Ability to monitor infectious disease in primary healthcare centers and rampant growth in global IT-healthcare sector drive the software solutions market growth. Services are growing at a steady pace due to the entry of numerous market participants providing outsourcing solutions pertaining to infection surveillance.

Urinary tract infection is reigning the type segment for infection surveillance solutions market. Prolonged use of a catheter and an increasing number of immunocompromised patients drive urinary tract infections. Other infections such as MRSA and pneumonia will register impressive growth due to growing antibiotic resistance and lack of treatment regimen to counteract their deleterious effects.

Hospitals are currently dominating the end-use segment for infection surveillance solutions market. A significant rise in the number of surgeries performed an increasing number of inbound patients drive the hospitals market growth. Long term care centers will be growing at a faster pace on account of its ability to treat patients suffering from antibiotic resistance by a microorganism and increasing outbound patients due to low healthcare cost incurred.

North America is the clear leader in the regional segment for infection surveillance solutions with 35% market share. The major contributing factors related to its overwhelming market growth are increasing cases of hospital-acquired infections and the existence of a well-developed healthcare framework.

Europe with a share of 30% is the second largest regional market owing to proactive government policies in reducing mortality associated with infectious disease and increasing funding in life science research and development segment to counteract antibiotic resistance by bacteria.

The Asia Pacific represents 20% share on account of increasing healthcare burden on primary healthcare centers associated with infectious disease and rising public health awareness.

IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions, and Wolters Kluwer N.V.

Key Market Movements

  • The rising prevalence of infectious disease and antibiotic resistance by bacteria
  • Availability of different configuration solutions making real-time infection surveillance successful
  • An increasing number of primary healthcare centers and IT-healthcare market participants worldwide

Topics Covered

Chapter 1. Preface

1.1. Report Scope and Description

1.2. Research Scope

1.3. Research Methodology

1.4. Market Segmentation

Chapter 2. Executive Summary

2.1. Global Infection Surveillance Solutions Market Portraiture

2.2. Global Infection Surveillance Solutions Market, by Product, 2017 (US$ Mn)

2.3. Global Infection Surveillance Solutions Market, by Type, 2017 (US$ Mn)

2.4. Global Infection Surveillance Solutions Market, by End-Use, 2017 (US$ Mn)

2.5. Global Infection Surveillance Solutions Market, by Geography, 2017 (US$ Mn)

Chapter 3. Infection Surveillance Solutions Market: Dynamics and Future Outlook

3.1. Market Overview

3.2. Drivers

3.3. Challenges

3.4. Opportunities

3.5. Attractive Investment Proposition, by Geography, 2017

3.6. Competitive Analysis: Global Infection Surveillance Solutions Market, by Key Players, 2017

Chapter 4. Global Infection Surveillance Solutions Market, by Product

4.1. Overview

4.2. Services

4.3. Software

Chapter 5. Global Infection Surveillance Solutions Market, by Type

5.1. Urinary Tract Infection

5.2. Surgical Site Infection

5.3. Blood Stream Infection

5.4. Others

Chapter 6. Global Infection Surveillance Solutions Market, by End-Use

6.1. Overview

6.2. Hospitals

6.3. Long Term Care Centers

6.4. Others

Chapter 7. Global Infection Surveillance Solutions Market, by Geography

7.1. Overview

7.2. North America Infection Surveillance Solutions Market Analysis, 2016 - 2026

7.3. Europe Infection Surveillance Solutions Market Analysis, 2016 - 2026

7.4. Asia Pacific Infection Surveillance Solutions Market Analysis, 2016 - 2026

7.5. Latin America Infection Surveillance Solutions Market Analysis, 2016 - 2026

7.6. Middle East and Africa Infection Surveillance Solutions Market Analysis, 2016 - 2026

Chapter 8. Company Profiles

8.1. Atlas Medical Software

8.1.1. Business Description

8.1.2. Financial Information (Subject to data availability)

8.1.3. Product Portfolio

8.1.4. News Coverage

8.2. Becton Dickinson and Company

8.3. Baxter International, Inc.

8.4. Deb Group Ltd.

8.5. Gojo Industries, Inc.

8.6. Hygreen, Inc.

8.7. Premier, Inc.

8.8. RL Solutions

8.9. Truven Health Analytics

8.10. Wolters Kluwer N.V.

For more information about this report visit https://www.researchandmarkets.com/research/z846cw/infection?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190403005623/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/03/2019 10:59 AM/DISC: 04/03/2019 10:59 AM

http://www.businesswire.com/news/home/20190403005623/en